Skip to main content
. 2020 Feb 27;5(4):e132048. doi: 10.1172/jci.insight.132048

Figure 6. Increased CCL7 in the serum and CD11c+ PBMCs of PLCH patients.

Figure 6

(A) CCL7 levels were measured in the serum of never smokers (n = 10), current smokers (n = 10), and PLCH patients (n = 22) by ELISA. Groups were compared using Kruskal-Wallis 1-way analysis of variance on ranks with Dunn’s multiple-comparisons test. *P < 0.05. (B) PBMCs were isolated from healthy controls and PLCH patients and treated with or without LPS and IFN-γ overnight. The CCL7+ cells were identified exclusively in the CD11c+ population of PBMCs by flow cytometry. Representative plots from 3 patients and controls are shown.